title: [Experimental justification of the use of benzimidazole derivatives as antiasthenic agents after craniocerebral trauma].
abstract: Experimental administration of benzimidazole derivatives upon model craniocerebral trauma favored rapid normalization of the behavior of hypoxia-sensitive animals and prevented from excess activation of lipid peroxidation processes in the brain. It is recommended to use benzimidazole derivatives for the control of free-radical processes and the correction of psychopathologic disorders in cases of post-trauma cerebroasthenia.
authors.forename: I V
authors.initials: IV
authors.lastname: Zarubina
authors.forename: F N
authors.initials: FN
authors.lastname: Nurmanbetova
authors.forename: P D
authors.initials: PD
authors.lastname: Shabanov
mesh_terms: D000818:Animals; D001247:Asthenia / Q000209:etiology / Q000517:prevention & control*; D001522:Behavior, Animal / Q000187:drug effects; D001562:Benzimidazoles / Q000494:pharmacology / Q000627:therapeutic use*; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D006259:Craniocerebral Trauma / Q000188:drug therapy* / Q000378:metabolism; D000860:Hypoxia / Q000188:drug therapy; D015227:Lipid Peroxidation / Q000187:drug effects; D008297:Male; D018696:Neuroprotective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D011919:Rats, Inbred Strains
chemical_list: D001562:Benzimidazoles; D018696:Neuroprotective Agents